Anti-Virulence Therapeutic Approaches for

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2021 Jan 26

PMID 33494538

Citations 9

Authors

Katherine Y L Lim

Christopher A Mullally

Ethan C Haese

Emily A Kibble

Nicolie R McCluskey

Edward C Mikucki

Van C Thai

Keith A Stubbs

Mitali Sarkar-Tyson

Charlene M Kahler

Affiliations

Soon will be listed here.

Abstract

While antimicrobial resistance (AMR) is seen in both and , the former has become resistant to commonly available over-the-counter antibiotic treatments. It is imperative then to develop new therapies that combat current AMR isolates whilst also circumventing the pathways leading to the development of AMR. This review highlights the growing research interest in developing anti-virulence therapies (AVTs) which are directed towards inhibiting virulence factors to prevent infection. By targeting virulence factors that are not essential for gonococcal survival, it is hypothesized that this will impart a smaller selective pressure for the emergence of resistance in the pathogen and in the microbiome, thus avoiding AMR development to the anti-infective. This review summates the current basis of numerous anti-virulence strategies being explored for .

Citing Articles

Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea Infection.

Mulaudzi V, Adeosun I, Adewumi A, Soliman M, Cosa S Int J Mol Sci. 2025; 25(24.

PMID: 39769078 PMC: 11677219. DOI: 10.3390/ijms252413310.

Sore throat, dysuria in a promiscuous male: What is your diagnosis?.

Revathi K, Vedhanayagam M, Rajagopalan R, Subrahmanya K Indian J Sex Transm Dis AIDS. 2024; 45(1):78-79.

PMID: 38989082 PMC: 11233053. DOI: 10.4103/ijstd.ijstd_38_24.

Effect of C7-3-Peptide-Loaded Chitosan Nanoparticles Against Multi-Drug-Resistant .

Albdrawy A, Aleanizy F, Eltayb E, Aldossari A, Alanazi M, Alfaraj R Int J Nanomedicine. 2024; 19:609-631.

PMID: 38264736 PMC: 10804975. DOI: 10.2147/IJN.S445737.

Current State of Knowledge Regarding WHO High Priority Pathogens-Resistance Mechanisms and Proposed Solutions through Candidates Such as Essential Oils: A Systematic Review.

Romanescu M, Oprean C, Lombrea A, Badescu B, Teodor A, Constantin G Int J Mol Sci. 2023; 24(11).

PMID: 37298678 PMC: 10253476. DOI: 10.3390/ijms24119727.

Bacterium of one thousand and one variants: genetic diversity of pathogenicity.

Kurzyp K, Harrison O Microb Genom. 2023; 9(6).

PMID: 37285200 PMC: 10327513. DOI: 10.1099/mgen.0.001040.

References

Zielke R, Le Van A, Baarda B, Herrera M, Acosta C, Jerse A . SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection. PLoS Pathog. 2018; 14(7):e1007081. PMC: 6033465. DOI: 10.1371/journal.ppat.1007081. View

McMahon R, Ireland P, Sarovich D, Petit G, Jenkins C, Sarkar-Tyson M . Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB. Infect Immun. 2018; 86(5). PMC: 5913862. DOI: 10.1128/IAI.00938-17. View

Ragland S, Humbert M, Christodoulides M, Criss A . Neisseria gonorrhoeae employs two protein inhibitors to evade killing by human lysozyme. PLoS Pathog. 2018; 14(7):e1007080. PMC: 6033460. DOI: 10.1371/journal.ppat.1007080. View

Adams L, Sharma P, Mohanty B, Ilyichova O, Mulcair M, Williams M . Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA. Angew Chem Int Ed Engl. 2015; 54(7):2179-84. DOI: 10.1002/anie.201410341. View

Hill S, Masters T, Wachter J . Gonorrhea - an evolving disease of the new millennium. Microb Cell. 2017; 3(9):371-389. PMC: 5354566. DOI: 10.15698/mic2016.09.524. View

Brandts J, Halvorson H, Brennan M . Consideration of the Possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry. 1975; 14(22):4953-63. DOI: 10.1021/bi00693a026. View

Schiene-Fischer C, Yu C . Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett. 2001; 495(1-2):1-6. DOI: 10.1016/s0014-5793(01)02326-2. View

van Putten J, Paul S . Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J. 1995; 14(10):2144-54. PMC: 398320. DOI: 10.1002/j.1460-2075.1995.tb07208.x. View

Cosgrove S . The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2005; 42 Suppl 2:S82-9. DOI: 10.1086/499406. View

10.

Gomez-Duarte O, Dehio M, Guzman C, Chhatwal G, Dehio C, Meyer T . Binding of vitronectin to opa-expressing Neisseria gonorrhoeae mediates invasion of HeLa cells. Infect Immun. 1997; 65(9):3857-66. PMC: 175551. DOI: 10.1128/iai.65.9.3857-3866.1997. View

11.

Greiner L, Edwards J, Shao J, Rabinak C, Entz D, Apicella M . Biofilm Formation by Neisseria gonorrhoeae. Infect Immun. 2005; 73(4):1964-70. PMC: 1087446. DOI: 10.1128/IAI.73.4.1964-1970.2005. View

12.

Vivian J, Scoullar J, Rimmer K, Bushell S, Beddoe T, Wilce M . Structure and function of the oxidoreductase DsbA1 from Neisseria meningitidis. J Mol Biol. 2009; 394(5):931-43. DOI: 10.1016/j.jmb.2009.09.065. View

13.

Wu H, Jerse A . Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infect Immun. 2006; 74(7):4094-103. PMC: 1489707. DOI: 10.1128/IAI.00433-06. View

14.

Warner D, Shafer W, Jerse A . Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol. 2008; 70(2):462-78. PMC: 2602950. DOI: 10.1111/j.1365-2958.2008.06424.x. View

15.

Takayama K, Qureshi N, Hyver K, Honovich J, Cotter R, Mascagni P . Characterization of a structural series of lipid A obtained from the lipopolysaccharides of Neisseria gonorrhoeae. Combined laser desorption and fast atom bombardment mass spectral analysis of high performance liquid chromatography-purified dimethyl.... J Biol Chem. 1986; 261(23):10624-31. View

16.

Thompson T, SWANSON R, Wiesner P . Gonococcal ophthalmia neonatorum. Relationship of time of infection to relevant control measures. JAMA. 1974; 228(2):186-8. DOI: 10.1001/jama.228.2.186. View

17.

Skalweit M, Li M . Bulgecin A as a β-lactam enhancer for carbapenem-resistant and carbapenem-resistant clinical isolates containing various resistance mechanisms. Drug Des Devel Ther. 2016; 10:3013-3020. PMC: 5036594. DOI: 10.2147/DDDT.S110193. View

18.

McGee Z, Stephens D, Hoffman L, Schlech 3rd W, Horn R . Mechanisms of mucosal invasion by pathogenic Neisseria. Rev Infect Dis. 1983; 5 Suppl 4:S708-14. DOI: 10.1093/clinids/5.supplement_4.s708. View

19.

Cloud K, Dillard J . A lytic transglycosylase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production. Infect Immun. 2002; 70(6):2752-7. PMC: 127960. DOI: 10.1128/IAI.70.6.2752-2757.2002. View

20.

Lelouard H, Henri S, de Bovis B, Mugnier B, Chollat-Namy A, Malissen B . Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's patch dendritic cells that express lysozyme. Gastroenterology. 2009; 138(1):173-84.e1-3. DOI: 10.1053/j.gastro.2009.09.051. View